机译:配体结合质谱法研究融合蛋白药物的生物转化并指导免疫测定的发展:战略方法和对靶向血小板生成素受体的肽体的应用。
Department of PKDM Amgen Inc. One Amgen Center Drive Mail Stop 30E-3-C Thousand Oaks California 91320 USA;
Department of Protein Science Amgen Inc. Thousand Oaks California 91320 USA;
Department of Protein Science Amgen Inc. Thousand Oaks California 91320 USA;
Department of Protein Science Amgen Inc. Thousand Oaks California 91320 USA;
Department of PKDM Amgen Inc. One Amgen Center Drive Mail Stop 30E-3-C Thousand Oaks California 91320 USA;
Department of PKDM Amgen Inc. One Amgen Center Drive Mail Stop 30E-3-C Thousand Oaks California 91320 USA;
Department of PKDM Amgen Inc. One Amgen Center Drive Mail Stop 30E-3-C Thousand Oaks California 91320 USA;
Department of PKDM Amgen Inc. One Amgen Center Drive Mail Stop 30E-3-C Thousand Oaks California 91320 USA;
Department of Protein Science Amgen Inc. Thousand Oaks California 91320 USA;
Department of PKDM Amgen Inc. One Amgen Center Drive Mail Stop 30E-3-C Thousand Oaks California 91320 USA;
Department of PKDM Amgen Inc. One Amgen Center Drive Mail Stop 30E-3-C Thousand Oaks California 91320 USA;
fusion protein biotransformation; in vivo stability of biopharmaceuticals; immunoaffinity-mass spectrometry; ligand-binding assay; peptibodies;
机译:配体结合质谱结合ELISA定量分析融合蛋白四联蛋白-载脂蛋白A1的体内生物转化
机译:差异酶联免疫吸附测定和配体结合质谱分析蛋白质疗法的生物转化:在多种FGF21方式中的应用
机译:发布原稿的新准则,描述肽和蛋白质靶向质谱测量的开发和应用
机译:用于了解高分子药物生物转化和影响免疫测定量化的配体结合质谱法
机译:比例脉冲烷基化质谱法:用于研究金属蛋白中蛋白质折叠和螯合稳定性的方法开发和应用。
机译:配体结合质谱法研究融合蛋白药物的生物转化并指导免疫测定的发展:战略方法和对靶向血小板生成素受体的肽体的应用。
机译:配体结合质谱法研究融合蛋白药物的生物转化并指导免疫测定的发展:战略方法和对靶向血小板生成素受体的肽体的应用。